Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
20 aug 2015 - 10:00
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug AG to Publish First Half 2015 Results on 27 August, 2015
Bericht
HALLE/SAALE, Germany, 20 August 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), will publish its results for the first six months 2015 on August 27, 2015. The company will host a conference call open to the public on August 27, 2015 at 15:00 Central European Time (CET).
Datum laatste update: 03 september 2024